IMMONC (Immune Oncology Research Institute) is a brand committed to advancing research in the prevention, treatment, and cure of cancer, with a strong focus on making these innovations accessible to those who need them. Founded in April 2022 by renowned pediatric oncologist Gevorg Tamamyan, oncologist Samvel Bardakhchyan, and hematologist Astghik Voskanyan, IMMONC believes in the power of international collaboration to achieve significant advancements in cancer care and outcomes.

With a dedicated team of researchers, IMMONC is determined to make a difference in the lives of cancer patients and their loved ones. Their goals include advancing cancer knowledge through breakthrough scientific research, integrating innovative immune-oncology therapies into clinical practice, generating and collecting clinical data for the identification of new therapeutic targets, and optimizing patient outcomes. They also strive to increase the availability and accessibility of their discoveries for cancer patients.

Additionally, IMMONC aims to create a world-class professional environment and attract the brightest minds in the cancer field while training the next generation of leading cancer researchers.

To learn more about IMMONC or express interest in joining their team, you can contact them at [email protected] or call +374-41 310-048.